Appeal No. 1998-2267
Application 08/339,084
of ursodeoxycholic acid, a pharmaceutically acceptable salt thereof or a pharmaceutically
acceptable ester thereof.
The prior art references relied upon by the examiner are:
1
Shironaga JP 61-158995 KOKAI July 18, 1986
Podda et al. (Podda), “Effect of Different Doses of Ursodeoxycholic Acid in Chronic Liver
Disease”, Digestive Diseases and Sciences, Vol. 34., No. 12, pp. 59S-69S (1989)
Reference relied on by appellant:
(Kaplowitz), Biliary Diseases, pp. 327-337, 383, 445-446 and index, (Neil Kaplowitz ed.,
Wilkins and Wilkins 1992)
Ground of Rejection
Claims 1-8 stand rejected under 35 U.S.C. § 103 over Podda in view of Shironaga.
DISCUSSION
In reaching our decision in this appeal, we have given consideration to the
appellant's specification and claims, to the applied prior art references, and to the
respective positions articulated by the appellant and the examiner.
Rather than reiterate the conflicting viewpoints advanced by the examiner and the
appellant regarding the noted rejection, we make reference to the examiner's Answer for
1The examiner relied on an abstract of the Japanese patent application from
HCAPLUS (Abstract 224). Appellant provided an English translation of the entire
Japanese patent application with the Brief (Appendix IV), which we rely on for purposes of
this appeal.
2
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007